Diagnostic Imaging's editors work hard to make the magazine engaging, but inevitably the conversation is a bit one-sided. We hope to change that for one night this month, with a Diagnostic Imaging Symposium: Strategic Outlook on Radiology's Future.
Diagnostic Imaging's editors work hard to make the magazine engaging, but inevitably the conversation is a bit one-sided. We hope to change that for one night this month, with a Diagnostic Imaging Symposium: Strategic Outlook on Radiology's Future.
This event is a rare opportunity to hear directly from some of the brightest thinkers in the specialty. Our speakers are tasked with describing trends that will shape imaging practice in the coming years-economics, politics, clinical advances, and technology and workflow-and offering strategies to make the most of them as individuals, practice groups, and as a specialty.
Regardless of subspecialty or practice style, the symposium should capture your interest. Dr. Sanjiv Gambhir of Stanford University's molecular imaging program will discuss the evolution of oncology imaging across modalities and into the molecular arena. Dr. Tom Brady from Massachusetts General Hospital will outline radiology's role in the transformation of cardiovascular imaging. Dr. Elliot Fishman from Johns Hopkins will map techniques for interpreting and managing volume data sets. Dr. Eliot Siegel from the Maryland VA will describe workflow technologies and techniques to improve daily practice. The end result, we hope, will be clear steps that can help our guests prepare themselves and their practices to succeed in an evolving medical environment.
Please join us Monday, Nov. 28, at the Millennium Knickerbocker Hotel in Chicago. There is no charge for this dinner event, but space is limited. Visit www. cmellc. com/disymposia to register or call (800) 447-4474. We hope to see you there!
Ms. Lowers is special projects editor for Diagnostic Imaging.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.